104 related articles for article (PubMed ID: 413873)
21. Mechanism of inhibition by trinitrophenylation of the ristocetin cofactor activity of von Willebrand factor.
Santoro SA; Cowan JF
Biochim Biophys Acta; 1984 Feb; 797(2):178-85. PubMed ID: 6607747
[TBL] [Abstract][Full Text] [Related]
22. Electron microscopy of human factor VIII/Von Willebrand glycoprotein: effect of reducing reagents on structure and function.
Ohmori K; Fretto LJ; Harrison RL; Switzer ME; Erickson HP; McKee PA
J Cell Biol; 1982 Nov; 95(2 Pt 1):632-40. PubMed ID: 6815213
[TBL] [Abstract][Full Text] [Related]
23. Structure - function relationship of factor VIII/von Willebrand factor. Application to the study of variant von Willebrand's disease and cryosupernatant prepared from normal plasma.
Pietu G; Obert B; Larrieu MJ; Meyer D
Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):671-85. PubMed ID: 6777898
[No Abstract] [Full Text] [Related]
24. Content and functional activity of von Willebrand factor in apheresis plasma.
Burnouf T; Caron C; Burkhardt T; Goudemand J
Vox Sang; 2004 Jul; 87(1):27-33. PubMed ID: 15260819
[TBL] [Abstract][Full Text] [Related]
25. [Factor VIII/von Willebrand factor complex (FVIII/vWF)].
Yoshioka A
Rinsho Byori; 1985 Feb; Spec No 61():73-85. PubMed ID: 3923232
[No Abstract] [Full Text] [Related]
26. [Structure and function of the factor VIII/von Willebrand factor complex].
Müller G
Z Gesamte Inn Med; 1990 Mar; 45(3):65-8. PubMed ID: 2159676
[TBL] [Abstract][Full Text] [Related]
27. The factor VIII complex: structure and function.
Hoyer LW
Prog Clin Biol Res; 1981; 72():1-26. PubMed ID: 6801681
[TBL] [Abstract][Full Text] [Related]
28. The complex multimeric composition of factor VIII/von Willebrand factor.
Ruggeri ZM; Zimmerman TS
Blood; 1981 Jun; 57(6):1140-3. PubMed ID: 6784794
[TBL] [Abstract][Full Text] [Related]
29. Abnormal antigenic reactivity of factor VIII/von Willebrand factor subunit in variants of von Willebrand's disease.
Girma JP; Pietu G; Lavergne JM; Meyer D; Larrieu MJ
J Lab Clin Med; 1982 Apr; 99(4):481-94. PubMed ID: 6174657
[TBL] [Abstract][Full Text] [Related]
30. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D
J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
[TBL] [Abstract][Full Text] [Related]
31. A critical evaluation of the available methods for the determination of factor VIII von Willebrand.
Casonato A; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):670-84. PubMed ID: 2435633
[TBL] [Abstract][Full Text] [Related]
32. Purification of three porcine immunoglobulin classes from the same biological source.
Phan Thanh L; Paraf A
Ann Rech Vet; 1987; 18(3):261-7. PubMed ID: 3122627
[TBL] [Abstract][Full Text] [Related]
33. Silver staining of high molecular weight proteins on large-pore polyacrylamide gels.
Perret BA; Felix R; Furlan M; Beck EA
Anal Biochem; 1983 May; 131(1):46-50. PubMed ID: 6193732
[TBL] [Abstract][Full Text] [Related]
34. Support of ristocetin-induced platelet aggregation by procoagulant-inactive and plasmin-cleaved forms of human factor VIII/von Willebrand factor.
Andersen JC; Switzer ME; McKee PA
Blood; 1980 Jan; 55(1):101-8. PubMed ID: 6444272
[No Abstract] [Full Text] [Related]
35. Plasmin digestion of factor VIII: characterization of the breakdown products with respect to antigenicity and von Willebrand activity.
Guisasola JA; Cockburn CG; Hardisty RM
Thromb Haemost; 1978 Oct; 40(2):302-15. PubMed ID: 153594
[No Abstract] [Full Text] [Related]
36. Isolation of small molecular forms of Factor VIII/von Willebrand factor from plasma.
Perret BA; Furlan M; Beck EA
Haemostasis; 1984; 14(4):289-95. PubMed ID: 6437941
[TBL] [Abstract][Full Text] [Related]
37. Dispersity of human factor VIII--Von Willebrand factor.
van Mourik JA; Bolhuis PA
Thromb Res; 1978 Jul; 13(1):15-24. PubMed ID: 308712
[No Abstract] [Full Text] [Related]
38. A novel core fractionation process of human plasma by expanded bed adsorption chromatography.
Lihme A; Hansen MB; Andersen IV; Burnouf T
Anal Biochem; 2010 Apr; 399(1):102-9. PubMed ID: 19995544
[TBL] [Abstract][Full Text] [Related]
39. Enzymatic degradation of the factor-VIII-von-Willebrand protein: a unique tryptic fragment with ristocetin cofactor activity.
Martin SE; Marder VJ; Francis CW; Loftus LS; Barlow GH
Blood; 1980 May; 55(5):848-58. PubMed ID: 6767513
[No Abstract] [Full Text] [Related]
40. Carbohydrate on human factor VIII/von Willebrand factor. Impairment of function by removal of specific galactose residues.
Sodetz JM; Paulson JC; Pizzo SV; McKee PA
J Biol Chem; 1978 Oct; 253(20):7202-6. PubMed ID: 100492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
